Viewing StudyNCT00020930



Ignite Creation Date: 2024-05-05 @ 11:24 AM
Last Modification Date: 2024-10-26 @ 9:06 AM
Study NCT ID: NCT00020930
Status: COMPLETED
Last Update Posted: 2009-12-04
First Post: 2001-07-11

Brief Title: Cetuximab in Treating Patients With Stage IV Colorectal Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
Organization: National Cancer Institute NCI

Organization Data

Organization: National Cancer Institute NCI
Class: NIH
Study ID: CDR0000068731
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Memorial Sloan Kettering Cancer Center
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
National Cancer Institute NCI NIH